These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 14570153
1. Cholecystokinin and learning and memory processes. Hadjiivanova C, Belcheva S, Belcheva I. Acta Physiol Pharmacol Bulg; 2003; 27(2-3):83-8. PubMed ID: 14570153 [Abstract] [Full Text] [Related]
4. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations. Kõks S, Männistö PT, Bourin M, Shlik J, Vasar V, Vasar E. J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682 [Abstract] [Full Text] [Related]
5. [Is cholecystokinin a biological support in panic attacks?]. Bourin M, Bradwejn J, Koszycki D. Encephale; 1991 Jan; 17(5):475-9. PubMed ID: 1686250 [Abstract] [Full Text] [Related]
6. [Receptors for cholecystokinin and gastrin]. de Weerth A, Bläker M, von Schrenck T. Z Gastroenterol; 1999 May; 37(5):389-401. PubMed ID: 10413847 [Abstract] [Full Text] [Related]
7. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence. Ballaz SJ, Akil H, Watson SJ. Neurosci Lett; 2007 Nov 20; 428(1):27-32. PubMed ID: 17950531 [Abstract] [Full Text] [Related]
8. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Hebb AL, Poulin JF, Roach SP, Zacharko RM, Drolet G. Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec 20; 29(8):1225-38. PubMed ID: 16242828 [Abstract] [Full Text] [Related]
9. Cholecystokinin antagonists: pharmacological and therapeutic potential. Herranz R. Med Res Rev; 2003 Sep 20; 23(5):559-605. PubMed ID: 12789687 [Abstract] [Full Text] [Related]
15. Cholecystokinin and panic disorder: past and future clinical research strategies. Bradwejn J, Koszycki D. Scand J Clin Lab Invest Suppl; 2001 Dec 20; 234():19-27. PubMed ID: 11713976 [Abstract] [Full Text] [Related]
16. The CCK(-like) receptor in the animal kingdom: functions, evolution and structures. Staljanssens D, Azari EK, Christiaens O, Beaufays J, Lins L, Van Camp J, Smagghe G. Peptides; 2011 Mar 20; 32(3):607-19. PubMed ID: 21167241 [Abstract] [Full Text] [Related]
17. Cholecystokinin and anxiety: promises and pitfalls. Rodgers RJ, Johnson NJ. Crit Rev Neurobiol; 1995 Mar 20; 9(4):345-69. PubMed ID: 8829850 [Abstract] [Full Text] [Related]
19. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus. Farook JM, Zhu YZ, Wang Q, Moochhala SM, Lee L, Wong PT. Neurosci Lett; 2004 Apr 01; 358(3):215-9. PubMed ID: 15039119 [Abstract] [Full Text] [Related]
20. Cholecystokinin (CCK) and CCK receptor expression by human gliomas: Evidence for an autocrine/paracrine stimulatory loop. Oikonomou E, Buchfelder M, Adams EF. Neuropeptides; 2008 Jun 01; 42(3):255-65. PubMed ID: 18423848 [Abstract] [Full Text] [Related] Page: [Next] [New Search]